TYBR Health, Inc.
TYBR Health is dedicated to improving post-surgical recovery by bridging the gap between surgical success and functional recovery. Their mission is to help patients regain full movement after tendon repairs by reducing tissue tethering and scarring with their innovative B3 GEL technology. They aim to enhance surgical outcomes, reduce recovery time, and improve quality of life for patients through advanced tissue care solutions.
Industries
Nr. of Employees
small (1-50)
TYBR Health, Inc.
Houston, Texas, United States, North America
Products
Anti-adhesion surgical gel (surgical adjunct)
A gel-formulated biomaterial applied intraoperatively to reduce excessive post-operative tissue tethering (adhesions) and support restoration of movement after tendon and soft-tissue repairs.
Anti-adhesion surgical gel (surgical adjunct)
A gel-formulated biomaterial applied intraoperatively to reduce excessive post-operative tissue tethering (adhesions) and support restoration of movement after tendon and soft-tissue repairs.
Services
Clinical and commercial partnership engagement
Direct engagement with surgeons, distributors, and investors to discuss clinical use, distribution, and commercial opportunities for post-surgical tissue-care technology.
Clinical and commercial partnership engagement
Direct engagement with surgeons, distributors, and investors to discuss clinical use, distribution, and commercial opportunities for post-surgical tissue-care technology.
Expertise Areas
- Anti-adhesion biomaterials
- Surgical adjunct development
- Post-surgical functional recovery
- Clinical outcomes research related to adhesions
Key Technologies
- Gel-based biomaterials / hydrogels
- Anti-adhesion barrier technology
- Surgical adjunct application methods
- Clinical outcome measurement